Detalles de la búsqueda
1.
Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japanã- Results From Post-Marketing Surveillance (XASSENT).
Circ J
; 87(9): 1175-1184, 2023 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245989
2.
Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib.
Future Oncol
; 18(11): 1371-1380, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023360
3.
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes.
Graefes Arch Clin Exp Ophthalmol
; 260(11): 3489-3498, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35652946
4.
Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI).
Eur J Contracept Reprod Health Care
; 27(4): 300-307, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611632
5.
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents.
Int J Clin Oncol
; 26(4): 753-763, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575828
6.
Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.
Heart Vessels
; 35(8): 1125-1134, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253531
7.
Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation.
Heart Vessels
; 35(3): 399-408, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31492970
8.
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan.
J Stroke Cerebrovasc Dis
; 29(4): 104584, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31983518
9.
Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting.
Oncologist
; 24(7): e450-e457, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606885
10.
Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
Cerebrovasc Dis
; 48(1-2): 53-60, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578012
11.
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings.
J Thromb Thrombolysis
; 48(4): 653-660, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31432451
12.
Correction to: Intravitreal aflibercept for diabetic macular edema in realworld clinical practice in Japan: 24month outcomes.
Graefes Arch Clin Exp Ophthalmol
; 261(1): 283-287, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472690
13.
A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.
Jpn J Clin Oncol
; 45(10): 953-62, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26206897
14.
Long-term surveillance provides real-world evidences of safety and effectiveness in intravitreal aflibercept treatment for age-related macular degeneration.
Sci Rep
; 13(1): 10597, 2023 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391547
15.
Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes.
Clin Ophthalmol
; 16: 579-592, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35256840
16.
Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment.
Cancer Chemother Pharmacol
; 89(6): 761-772, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35445315
17.
Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Contraception
; 116: 22-28, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057322
18.
Impact of three major risk factors on clinical outcomes in patients with nonvalvular atrial fibrillation receiving rivaroxaban: Sub-analysis from the XAPASS study.
J Arrhythm
; 38(3): 369-379, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785372
19.
[Exploratory Analysis Results from Post-marketing Surveillance Study of Radium-223 in Japanese Patients with Castration-resistant Prostate Cancer and Bone Metastases: Subgroup Analysis by Age].
Kaku Igaku
; 58(1): 91-101, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-34645727
20.
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
PLoS One
; 16(6): e0251325, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115769